Retatrutide, by Soma Pharmaceuticals , is receiving considerable attention as a potential method for weight management . This innovative compound merges the activity of a GLP-1 receptor activator and a GIP receptor stimulant, aiming to not only promote metabolic improvements but also improve associated metabolic issues . Initial clinical studies ha